申请人:Albany Molecular Research, Inc.
公开号:US07553846B2
公开(公告)日:2009-06-30
Compounds of formulae I and II:
are disclosed as 5-HT3 inhibitors. Those compounds are useful in treating CINV, IBS-D and other diseases and conditions.
化学式为I和II的化合物被披露为5-HT3抑制剂。这些化合物在治疗化疗诱导恶心和呕吐症(CINV)、腹泻型肠易激综合征(IBS-D)和其他疾病和情况方面有用。